Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-24 @ 10:00 PM
Ignite Modification Date: 2025-12-25 @ 7:37 PM
NCT ID: NCT01189032
Description: None
Frequency Threshold: 5
Time Frame: None
Study: NCT01189032
Study Brief: Late Phase II Confirmatory Study of DE-089 Ophthalmic Solution in Patients With Dry Eye
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
Placebo Placebo ophthalmic solution None None 0 94 17 94 View
Low Concentration 1% DE-089 ophthalmic solution None None 0 96 14 96 View
High Concentration 3% DE-089 ophthalmic solution None None 1 96 28 96 View
Serious Events(If Any):

Serious Events

Term Type Organ System Vocab View
Lung adenocarcinoma None Neoplasms benign, malignant and unspecified (incl cysts and polyps) MedDRA/J (8.1) View
Other Events(If Any):

Other Events

Term Type Organ System Vocab View
Eye irritation SYSTEMATIC_ASSESSMENT Eye disorders MedDRA/J (8.1) View
Eye pain SYSTEMATIC_ASSESSMENT Eye disorders MedDRA/J (8.1) View
Nasopharyngitis SYSTEMATIC_ASSESSMENT Infections and infestations MedDRA/J (8.1) View